Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022116 (
ischemia
)
91,303
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cyanidin 3-O-beta-D-glucoside
(
C3G
) is included in anthocyanins, and expected to have a potency to scavenge active oxygen species in vivo. Rats were fed a diet containing
C3G
(2 g/kg diet) for 14 days, and then subjected to hepatic
ischemia
-reperfusion (I/R) as an oxidative stress model. I/R treatment elevated the liver thiobarbituric acid-reactive substance concentration and the serum activities of marker enzymes for liver injury, and lowered the liver reduced glutathione concentration. Feeding
C3G
significantly suppressed these changes caused by hepatic I/R. These results indicate that
C3G
functions as a potent antioxidant in vivo under oxidative stress. To clarify the mechanism of action of
C3G
, we investigated the absorption and metabolism of
C3G
in rats.
C3G
appeared in the plasma immediately after the oral administration of
C3G
. Protocatechuic acid, which seems to be produced by the degradation of cyanidin, was also present in the plasma. In the liver and kidneys,
C3G
was metabolized to methylated form.
...
PMID:The role of anthocyanins as an antioxidant under oxidative stress in rats. 1123 72